Forward Looking Statements





This Interim Report on Form 10-Q contains, in addition to historical
information, certain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995 ("PLSRA"), Section 27A of the
Securities Act of 1933, as amended (the "Securities Act"), and section 21E of
the Securities Exchange Act of 1934, as amended (the "Exchange Act") regarding
Stem Holdings, Inc. (the "Company" or "Stem", also referred to as "us", "we" or
"our"). Forward-looking statements give our current expectations or forecasts of
future events. You can identify these statements by the fact that they do not
relate strictly to historical or current facts. Forward-looking statements
involve risks and uncertainties. Forward-looking statements include statements
regarding, among other things, (a) our projected sales, profitability, and cash
flows, (b) our growth strategies, (c) anticipated trends in our industries, (d)
our future financing plans and (e) our anticipated needs for working capital.
They are generally identifiable by use of the words "may," "will," "should,"
"anticipate," "estimate," "plans," "potential," "projects," "continuing,"
"ongoing," "expects," "management believes," "we believe," "we intend" or the
negative of these words or other variations on these words or comparable
terminology. These statements may be found under "Management's Discussion and
Analysis of Financial Condition and Results of Operations" and "Description of
Business," as well as in this Form 10-Q generally. In particular, these include
statements relating to future actions, prospective products or product
approvals, future performance or results of current and anticipated products,
sales efforts, expenses, the outcome of contingencies such as legal proceedings,
and financial results.



Any or all of our forward-looking statements in this report may turn out to be
inaccurate. They can be affected by inaccurate assumptions we might make or by
known or unknown risks or uncertainties. Consequently, no forward-looking
statement can be guaranteed. Actual future results may vary materially as a
result of various factors, including, without limitation, the risks outlined
under "Risk Factors" detailed in the Company's Form 10 and S-1 registration
statements and matters described in this Form 10-Q generally. In light of these
risks and uncertainties, there can be no assurance that the forward-looking
statements contained in this filing will in fact occur. You should not place
undue reliance on these forward-looking statements. The forward-looking
statements speak only as of the date on which they are made, and, except to the
extent required by federal securities laws, we undertake no obligation to
publicly update any forward-looking statements, whether as the result of new
information, future events, or otherwise. We intend that all forward-looking
statements be subject to the safe harbor provisions of the PSLRA.



For the three and nine months ended June 30, 2022, the financial statements have
been prepared by management in accordance with the standards of the Public
Company Accounting Oversight Board (United States). For the three and nine
months ended June 30, 2022, the unaudited interim financial statements have been
prepared by management in accordance with the condensing rules of the United
States Securities and Exchange Commission.



Results of Operations



                                        For the Three Months Ended June 30,                  Change
($ in thousands)                          2022                      2021                $              %
Gross Revenue                       $          4,823         $            6,362         (1,539 )          (24 )%
Discounts and returns                           (652 )                     (934 )          282            (30 )%
Cost of goods sold                             3,500                      3,948           (448 )          (11 )%
Consulting fees                                  104                        614           (510 )          (83 )%
Professional fees                                551                        849           (298 )          (35 )%
General and administration                     2,555                      3,489           (934 )          (27 )%
Other income, net                              3,011                      7,143         (4,132 )           58 %
Loss from discontinued operations                  -                     (1,082 )        1,082           (100 )%
Net income (loss)                   $            471         $            2,589



Comparison of the results of operations for the three months ended June 30, 2022, compared to the three months ended June 30, 2021





The Company had net revenues during the three months ended June 30, 2022, of
$4,171 compared with $5,428 for the comparable period of 2021, the decrease in
revenue was primarily related to a decrease in flower sales related to general
market conditions.



Cost of goods for the three months ended June 30, 2022, amounted to $3,500
compared to $3,948 in the comparable period of the prior year. These costs
include both the cost of finished product purchased for retail and the cost of
cultivation and processing for the grow facilities and sold at the wholesale
level.



In the three months ended June 30, 2022, we incurred consulting costs of $104
compared to $614 in the comparable period of the prior year. The decrease in
consulting fees was attributed to a decrease in stock-based consulting expenses.



In the three months ended June 30, 2022, we incurred professional fees of $551
compared to $849 in the comparable period of the prior year. Those fees are
primarily for legal, accounting, and related services that pertains to our being
a public company in both the United States and Canada.



In the three months ended June 30, 2022, we incurred general and administrative
costs of $2,555 compared to $3,489. This decrease relates primarily to a
decrease in costs related to advertising and promotion, office expenses, and
salaries.



40







                                        For the Nine Months Ended June 30,                   Change
($ in thousands)                          2022                      2021                $              %
Gross Revenue                       $          14,578         $          18,883         (4,305 )          (23 )%
Discounts and returns                          (2,061 )                  (2,697 )         (635 )          (24 )%
Cost of goods sold                             10,691                    10,969           (278 )           (3 )%
Consulting fees                                   633                     2,676         (2,043 )          (76 )%
Professional fees                               2,543                     2,635            (92 )           (3 )%
General and administration                      8,744                     8,385            359              4 %
Impairment of intangibles                         795                         -            795            100 %
Other income (expenses), net                    5,458                     1,109          4,349           (392 )%
Loss from discontinued operations              (1,745 )                  (1,946 )          201             10 %
Net loss                            $          (7,177 )       $          (9,316 )



Comparison of the results of operations for the nine months ended June 30, 2022, compared to the nine months ended June 30, 2021


The Company had net revenues during the nine months ended June 30, 2022, of
$12,517 compared with $16,186 for the comparable period of 2021, the decrease in
revenue was primarily related to a decrease in flower sales related to general
market conditions.



Cost of goods for the nine months ended June 30, 2022, amounted to $10,691
compared to $10,969 in the comparable period of the prior year. These costs
include both the cost of finished product purchased for retail and the cost of
cultivation and processing for the grow facilities and sold at the wholesale
level.



In the nine months ended June 30, 2022, we incurred consulting costs of $663
compared to $2,676 in the comparable period of the prior year. We mitigated our
consulting expenses which were stock based in the prior year.



In the nine months ended June 30, 2022, we incurred professional fees of $2,543
compared to $2,635 in the comparable period of the prior year. Those fees are
primarily for legal, accounting and related services relating to our being a
public company in both the United States and Canada.



In nine months ended June 30, 2022, we incurred general and administrative costs
of $8,744 compared to $8,385, these costs include payroll, depreciation and
amortization, insurance, rent expense and other general costs. We expect that
these costs will increase as we increase our operations.



LIQUIDITY AND FINANCIAL CONDITION

Liquidity and Capital Resources

The Company had cash of $3,400 as of June 30, 2022. On April 13, 2022, the Company closed on a stock purchase and note purchase agreement to sell its minority equity ownership interest in its Massachusetts cannabis license for a total of $1.65 million in cash.





Cash Flow


For the nine months ended June 30, 2022, and 2021





Net cash flows used in continuing operating activities was $5,764 for the nine
months ended June 30, 2022, as compared net cash flow used in continuing
operating activities to $6,653 for the nine months ended June 30, 2021, a change
of $889.



? Net cash flow used in operating activities for the nine months ended June 30,
2022 primarily reflected a net loss of $7,177 adjusted for the add-back of
non-cash items consisting of loss from discontinued operations of $1,745,
depreciation and amortization of approximately $1,247, stock-based compensation
and consulting expense of approximately $880, amortization of debt discount of
$13, amortization of intangible assets of $655, impairment of investments of
$288, issuance of common stock in connection with consulting agreements and
interest payments of $189, recognition of derivative liability of $340, offset
by a decrease in warrant liability of $2,183, gain on extinguishment of debt of
$803, foreign currency translation adjustment of $62, a gain from disposal of a
subsidiary of $831, gain on sale of property of $1,155, change operating assets
and liabilities consisting of a decrease in inventory of $21, a decrease in
accounts payable and accrued expenses of $124, a decrease in prepaids of $217,
an increase in other of $103, and a decrease in other assets of $1,402. Net cash
flow used in operating activities for the nine months ended June 30, 2021
primarily reflected a net loss of $9,316 adjusted for the add-back of non-cash
items consisting of loss from discontinued operations of $1,946, depreciation
and amortization of $3,745, stock-based compensation expense of $4,284, non-cash
rent and interest $331, amortization of debt discount of $606, and other
adjustments of $209 offset by the change in foreign currency translation of $29,
a gain in sale of equity method investments of $200, and a gain on the sale of a
property of $766, a change in the fair value of derivative and warrant
liabilities of $675, a change in operating assets and liabilities consisting of
an decrease in accounts payable and accrued expenses of $3,248, an increase in
prepaid expenses and other operating assets of $3,540.



41







? Net cash flow provided by investing activities for the nine months ended June
30, 2022, amounted to $3,329 and consisted of $206 used in the purchase of
property and equipment, $1,651 provided from the sale of an equity method
investment, and $2,173 provided from the sale of a property. Additionally, a net
of $288 was provided by investments, and $1 related to repayment of a related
party. Net cash flow provided by investing activities for the nine months ended
June 30, 2021, amounted to $591 and consisted of $425 used in the purchase of
property and equipment, $179 for project costs and an additional $560 was used
in investments, offset by cash received related to the sale of a property of
$1,505 and a net of $250 related to investment in equity method investees.



? Net cash provided by financing activities was $31 for the nine months ended
June 30, 2022, as compared to $14,985 for the nine months ended June 30, 2021.
During the nine months ended June 30, 2022, we received proceeds of $285 for the
issuance of common shares, $625 related to note payables offset by repayments of
$879 of notes payable. During the nine months ended June 30, 2021, we received
proceeds from the issuance of common shares of $17,713 offset by $1,697 of
repayment on notes payable was incurred and $1,031 for the forgiveness of debt.



CRITICAL ACCOUNTING POLICIES



Principles of Consolidation



The Company's policy is to consolidate all entities that it controls by
ownership of a majority of the outstanding voting stock. In addition, the
Company consolidates entities that meet the definition of a variable interest
entity ("VIE") for which it is the primary beneficiary. The primary beneficiary
is the party who has the power to direct the activities of a VIE that most
significantly impact the entity's economic performance and who has an obligation
to absorb losses of the entity or a right to receive benefits from the entity
that could potentially be significant to the entity. For consolidated entities
that are less than wholly owned, the third party's holding of equity interest is
presented as noncontrolling interests in the Company's Consolidated Balance
Sheets and Consolidated Statements of Changes in Stockholders' Equity. The
portion of net loss attributable to the noncontrolling interests is presented as
net loss attributable to noncontrolling interests in the Company's Consolidated
Statements of Operations.



Use of Estimates



The preparation of financial statements in conformity with GAAP requires
management to make estimates and assumptions that affect the application of
accounting policies and the reported amounts of assets, liabilities, income, and
expenses. The most significant estimates included in these consolidated
financial statements are those associated with the assumptions used to value
equity instruments, valuation of its long live assets for impairment testing,
valuation of intangible assets, and the valuation of inventory. These estimates
and assumptions are based on current facts, historical experience and various
other factors believed to be reasonable given the circumstances that exist at
the time the financial statements are prepared. Actual results may differ
materially and adversely from these estimates. To the extent there are material
differences between the estimates and actual results, the Company's future
results of operations will be affected.



Impairment of Long-Lived Assets





The Company reviews the carrying value of its long-lived assets, which include
property and equipment, for indicators of impairment whenever events or changes
in circumstances indicate that the carrying value of an asset or asset group may
not be recoverable. The Company considers the following to be some examples of
important indicators that may trigger an impairment review: (i) significant
under-performance or losses of assets relative to expected historical or
projected future operating results; (ii) significant changes in the manner or
use of assets or in the Company's overall strategy with respect to the manner or
use of the acquired assets or changes in the Company's overall business
strategy; (iii) significant negative industry or economic trends; (iv) increased
competitive pressures; (v) a significant decline in the Company's stock price
for a sustained period of time; and (vi) regulatory changes. The Company
evaluates assets for potential impairment indicators at least annually and more
frequently upon the occurrence of such events. The Company does not test for
impairment in the year of acquisition of properties, as long as those properties
are acquired from unrelated third parties.



The Company assesses the recoverability of its long-lived assets by comparing
the projected undiscounted net cash flows associated with the related long-lived
asset or group of long-lived assets over their remaining estimated useful lives
against their respective carrying amounts. In cases where estimated future net
undiscounted cash flows are less than the carrying value, an impairment loss is
recognized equal to an amount by which the carrying value exceeds the fair value
of the asset or asset group. Fair value is generally determined using the assets
expected future discounted cash flows or market value, if readily determinable.
If long-lived assets are determined to be recoverable, but the newly determined
remaining estimated useful lives are shorter than originally estimated, the net
book values of the long-lived assets are depreciated and amortized prospectively
over the newly determined remaining estimated useful lives.



42







An impairment expense of approximately $795,000 was recorded for the nine months
ended June 30, 2022. During the nine months ended June 30, 2021, the Company
determined that no impairment was required.



Goodwill and Intangible Assets

Goodwill. Goodwill represents the excess acquisition cost over the fair value of
net tangible and intangible assets acquired. Goodwill is not amortized and is
subject to annual impairment testing on or between annual tests if an event or
change in circumstance occurs that would more likely than not reduce the fair
value of a reporting unit below its carrying value. In testing for goodwill
impairment, the Company has the option to first assess qualitative factors to
determine whether the existence of events or circumstances lead to a
determination that it is more likely than not that the fair value of a reporting
unit is less than its carrying amount. If, after assessing the totality of
events and circumstances, the Company concludes that it is not more likely than
not that the fair value of a reporting unit is less than its carrying amount,
then performing the two-step impairment test is not required. If the Company
concludes otherwise, the Company is required to perform the two-step impairment
test. The goodwill impairment test is performed at the reporting unit level by
comparing the estimated fair value of a reporting unit with its respective
carrying value. If the estimated fair value exceeds the carrying value, goodwill
at the reporting unit level is not impaired. If the estimated fair value is less
than the carrying value, further analysis is necessary to determine the amount
of impairment, if any, by comparing the implied fair value of the reporting
unit's goodwill to the carrying value of the reporting unit's goodwill.



Intangible Assets. Intangible assets deemed to have finite lives are amortized
on a straight-line basis over their estimated useful lives, where the useful
life is the period over which the asset is expected to contribute directly, or
indirectly, to our future cash flows. Intangible assets are reviewed for
impairment on an interim basis when certain events or circumstances exist. For
amortizable intangible assets, impairment exists when the carrying amount of the
intangible asset exceeds its fair value. At least annually, the remaining useful
life is evaluated.



An intangible asset with an indefinite useful life is not amortized but assessed
for impairment annually, or more frequently, when events or changes in
circumstances occur indicating that it is more likely than not that the
indefinite-lived asset is impaired. Impairment exists when the carrying amount
exceeds its fair value. In testing for impairment, the Company has the option to
first perform a qualitative assessment to determine whether it is more likely
than not that an impairment exists. If it is determined that it is not more
likely than not that an impairment exists, a quantitative impairment test is not
necessary. If the Company concludes otherwise, it is required to perform a
quantitative impairment test. To the extent an impairment loss is recognized,
the loss establishes the new cost basis of the asset that is amortized over the
remaining useful life of that asset, if any. Subsequent reversal of impairment
losses is not permitted.


During the nine months ended June 30, 2022, and 2021, the Company determined that there were $0 and $0 losses related to the impairment of goodwill and intangible assets, respectively.





Business Combinations



The Company applies the provisions of ASC 805 in the accounting for
acquisitions. ASC 805 requires the Company to recognize separately from goodwill
the assets acquired, and the liabilities assumed at their acquisition date fair
values. Goodwill as of the acquisition date is measured as the excess of
consideration transferred over the net of the acquisition date fair values of
the assets acquired and the liabilities assumed. While the Company uses its best
estimates and assumptions to accurately apply preliminary value to assets
acquired and liabilities assumed at the acquisition date as well as contingent
consideration, where applicable, these estimates are inherently uncertain and
subject to refinement. As a result, during the measurement period, which may be
up to one year from the acquisition date, the Company records adjustments in the
current period, rather than a revision to a prior period. Upon the conclusion of
the measurement period or final determination of the values of the assets
acquired or liabilities assumed, whichever comes first, any subsequent
adjustments are recorded in the consolidated statements of operations.
Accounting for business combinations requires management to make significant
estimates and assumptions, especially at the acquisition date, including
estimates for intangible assets, contractual obligations assumed, restructuring
liabilities, pre-acquisition contingencies, and contingent consideration, where
applicable. Although the Company believes the assumptions and estimates made
have been reasonable and appropriate, they are based in part on historical
experience and information obtained from management of the acquired companies
and are inherently uncertain. Unanticipated events and circumstances may occur
that may affect the accuracy or validity of such assumptions, estimates, or

actual results.



43







Revenue Recognition



The Company recognizes revenue when its customer obtains control of promised
goods or services, in an amount that reflects the consideration which the entity
expects to receive in exchange for those goods or services. To determine revenue
recognition for arrangements that an entity determines are within the scope of
Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with
Customers (Topic 606), the entity performs the following five steps: (i)
identify the contract(s) with a customer; (ii) identify the performance
obligations in the contract; (iii) determine the transaction price; (iv)
allocate the transaction price to the performance obligations in the contract;
and (v) recognize revenue when (or as) the entity satisfies a performance
obligation. The Company only applies the five-step model to contracts when it is
probable that the entity will collect the consideration it is entitled to in
exchange for the goods or services it transfers to the customer. At contract
inception, once the contract is determined to be within the scope of Topic 606,
the Company assesses the goods or services promised within each contract and
determines those that are performance obligations and assesses whether each
promised good or service is distinct. The Company then recognizes as revenue the
amount of the transaction price that is allocated to the respective performance
obligation when (or as) the performance obligation is satisfied.



Revenue for the Company's product sales has not been adjusted for the effects of
a financing component as the Company expects, at contract inception, that the
period between when the Company's transfers control of the product and when the
Company receives payment will be one year or less. Product shipping and handling
costs are included in cost of product sales.



Effective October 1, 2019, the Company adopted the requirements of ASU 2014-09
(ASC 606) and related amendments, using the modified retrospective method. The
adoption of ASC 606 did not have a significant impact on the Company's revenue
recognition policy as revenues related to wholesale and retail revenue are
recorded upon transfer of merchandise to the customer, which was the effective
policy under ASC 605 previously.



The following policies reflect specific criteria for the various revenue streams of the Company:

Cannabis Dispensary, Cultivation and Production





Revenue is recognized upon transfer of retail merchandise to the customer upon
sale transaction, at which time its performance obligation is complete. Revenue
is recognized upon delivery of product to the wholesale customer, at which time
the Company's performance obligation is complete. Terms are generally between
cash on delivery to 30 days for the Company's wholesale customers.



The Company's sales environment is somewhat unique, in that once the product is
sold to the customer (retail) or delivered (wholesale) there are essentially no
returns allowed or warranty available to the customer under the various state
laws.



Delivery


1) Identify the contract with a customer






The Company sells retail products directly to customers. In these sales there is
no formal contract with the customer. These sales have commercial substance and
there are no issues with collectability as the customer pays the cost of the
goods at the time of purchase or delivery.



2) Identify the performance obligations in the contract






The Company sells its products directly to consumers. In this case these sales
represent a performance obligation with the sales and any necessary deliveries
of those products.


3) Determine the transaction price






The sales that are done directly to the customer have no variable consideration
or financing component. The transaction price is the cost that those goods are
being sold for plus any additional delivery costs.



4) Allocate the transaction price to performance obligations in the contract

For the goods that the Company sells directly to customers, the transaction price is allocated between the cost of the goods and any delivery fees that may be incurred to deliver to the customer.

5) Recognize revenue when or as the Company satisfies a performance obligation

For the sales of the Company's own goods the performance obligation is complete once the customer has received the product.





44






CONTRACTUAL OBLIGATIONS AND COMMITMENTS





As noted earlier in Note 1, the Company, engages in a business that constitutes
an illegal act under the laws of the United States Federal Government. This
raises several possible issues which may impact the Company's overall
operations, not the least of which are related to traditional banking and other
key operational risks. Since cannabis remains illegal on the federal level, and
most traditional banks are federally insured, those financial institutions will
not service cannabis businesses. In states where medical or recreational
marijuana is legal, dispensary owners, manufacturers, and anybody who "touches
the plant," continue to face a host of operational hurdles. While local,
state-chartered banks and credit unions now accept cannabis commerce, there
remains a reluctance by traditional banks to do business with them. Aside from a
huge inconvenience and the need to find creative ways to manage financial flow,
payroll logistics, and payment of taxes, this also poses tremendous risks to
controls as a result of operating a lucrative business in cash. This lack of
access to traditional banking may inhibit industry growth.



Despite the uncertainties surrounding the Federal government's position on legalized marijuana, the Company does not believe these risks will have a substantive impact on its planned operations in the near term.





As of June 30, 2022, the Company has acquired interests in several entities. As
part of those interests, the Company has commitments to fund the acquisition of
licenses and permits to allow for the cultivation and sale of cannabis and
related products in the United States. As of June 30, 2022, Company estimates
that its investees will need up to approximately $500,000 to complete the
acquisition of licenses and permits, to fund the buildout or expansion of
facilities to fully operate in their respective cannabis markets, which will
encompass several years of development.



OFF-BALANCE SHEET ARRANGEMENTS

The Company does not have any off-balance sheet arrangements.

© Edgar Online, source Glimpses